| Drug Type Small molecule drug | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), JAK inhibitors(Janus kinase inhibitors), Epigenetic drug | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhaseDiscontinuedPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | United States  | 01 Mar 2019 | 





